Common Dosage
Research phase (typically 10-50mg oral)
Category
Metabolic
- Increased energy expenditure
- Fat oxidation
- Insulin sensitivity
- No thermogenic side effects
BAM 15 (bis-amide compound) was developed by researchers including Kevin Bhatt and Kyle Hoehn, published in Nature Communications in 2020, as a safer alternative to 2,4-dinitrophenol (DNP) — the notoriously dangerous mitochondrial uncoupler that has been used illicitly for extreme fat loss but causes deaths from hyperthermia. BAM 15's key innovation is that it uncouples mitochondria without raising body temperature — eliminating the primary lethal mechanism of DNP.
Mitochondrial uncouplers dissipate the proton gradient across the inner mitochondrial membrane without generating ATP — converting the energy from oxidized nutrients into heat rather than chemical energy. This dramatically increases caloric expenditure. DNP achieves this through membrane diffusion but raises body temperature dangerously. BAM 15 uses a different mechanism (protonophore activity with different membrane kinetics) that increases energy expenditure and fat oxidation in animals without raising body temperature — the critical safety distinction.
- Obesity and fat loss research
- Insulin resistance improvement
- Non-alcoholic fatty liver disease management
- Metabolic efficiency research
- Safer alternative uncoupler development
Mouse Obesity Study
High-fat diet obese mice treated with BAM 15 showed significant fat loss, improved insulin sensitivity, and reduced liver fat without changes in food intake or body temperature — confirming the safety profile claimed for this compound in the initial publication.
- Human data is entirely absent — this is a very early-stage research compound
- Mitochondrial uncoupling is inherently dangerous — while BAM 15 appears safer than DNP, any protonophore activity carries risks not yet characterized in humans
- No established human dose — animal-to-human dose translation for metabolic compounds is non-linear
- Long-term mitochondrial health effects of sustained uncoupling are unknown
- Research peptide market versions lack any quality or safety standards
- Unknown long-term effects (Research)